Clinical Trials Browser

Phase 1/2 × Carcinoma, Merkel Cell × Radiation × Clear all

NCT02584829 2022-03-22

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Phase 1/2 Terminated

8 enrolled 16 charts

Carcinoma, Merkel Cell

NCT01758458 2017-04-19

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Phase 1/2 Terminated

Carcinoma, Merkel Cell